"Whale? I’m more of a diseased turtle" I was at a zoo

New Post Public Reply Private Reply Replies (2) Message Board
Respert24 Evil Rabbit #135408
599
"Whale? I’m more of a diseased turtle"

I was at a zoo one time, just there to remind all the animals that I'm the alpha roaming free while they're caged like little bitches. And while standing above a little nature area I heard the guy next to me excitedly say "HEY KIDS, LOOK! IT'S A TURTLE!!!" And then a couple beats later, deflated, he said "nope, it's just a rock".

Long story short, in this world of whales and diseased turtles, I'm a rock.

As I watch the trading today take an immediate chunk out of yesterday's gains, I'm reminded that there's really not much a company can do when there's no major catalysts dropping. In an already rigged system where the hedge funds, brokers, and institutions appear to have built-in advantages that we can see, I'm coming to realize they must have ten you can't see for every one that you can.

I watch a strong handful of biotech stocks, and have watched them for years. I've been in and out of some, or like with CYDY just in deeper and deeper. The inexplicable large drops in share price before a buyout comes, the 2 shares traded the moment premarket opens up to drop yesterday's closing price by 10%, the naked shorting, the walls put up as soon as momentum appears positive, the sell the news bullshit that shows an already massively undervalued stock drop by 30% after they get their drug approved.

It's insane.

So I wasn't at all surprised to watch yesterday's quick run up stall out, because I'm sure algorithms were triggered by the increase in both share price and volume resulting in people who can take advantage getting to work. Then today it didn't surprise me to see it drop at the open.

I still think people taking gains is a thing, or that rumors can catch on. I just don't think they're able to have any lasting impact in the face of those with power and money abusing the system they get to control. When a situation arises they just set their systems to fully automatic and let it rip.

That's your doom and gloom report from Chez Respert, where your hero is just annoyed that we didn't get a second day of large gains to help us crawl back toward a more respectable share price. I still have plenty of optimism and shares. I suppose I'm just tired of sitting around like a rock, unable to move or do anything to affect my situation while people with power and money dick around (technical trading term) with companies like CYDY seemingly at will.

If you ever want to play a sad game, go look at the stocktwits feed of any other biotech like CYDY. The complaints of shorts, the squeeze that never happens, the fda suppressing the drug, seeking alpha writing hit pieces, the inexplicable drops, the "they're just shaking out weak hands", etc. It's uncanny how familiar it is.

Now if you'll excuse me I'm going to go sit quietly in one place to watch the storm pass, hoping for skies to clear. Rock shit.



CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

CVS Health Under Fire: Fiduciary Duty Breach?

Updated Category News Views 3

CVS Under Regulatory Spotlight for Fiduciary Breaches You'd think by now companies would have their fiduciary ducks in a row. But here we are, with CVS Health Corporation (NYSE: CVS) catching heat from the legal eagles over at Halper Sadeh LLC. The knife’s out for some of the big wigs – apparently, there's chatter they might’ve slipped on their duty to play nice...

Continue Reading
Krispy Kreme Faces Legal Probe: Fiduciary Breach?

Updated Category News Views 3

Diving Deep into the Krispy Kreme Allegations Look, this isn't your run-of-the-mill donut drama. When you hear rumblings of corporate missteps, especially ones that involve potential breaches of fiduciary duties, it's time to perk up those ears. Over at Krispy Kreme, Inc. (NASDAQ:DNUT), there's some heat in the kitchen, and it's not just from frying those glazed beauties....

Continue Reading
Farm Aid 2026: A Resilient Tribute to Family Farmers

Updated Category News Views 6

Shining a Light on Essential Family Farmers Every year, thousands gather for Farm Aid to back the unsung heroes who put food on our plates. In 2026, the scene shifted to the amphitheater at Virginia Beach, where an epic lineup of music took stage not just to entertain but to underline a critical issue—family farmers are fighting for survival. These folks aren't merely...

Continue Reading
Jackson Wang's Fantasy IP Hits Hong Kong Stage

Updated Category News Views 5

A Star-Studded Fantasy Comes Alive Hong Kong isn't just about dim sum and skyline views—it's a magnet for celebrity showcases, and this time, Jackson Wang's pulling the strings. The guy's ventured beyond music and idol fame, diving head-first into creative visuals with his fantasy IP, "Under the Castle" (UTC). Pairing up with Ocean Park's Halloween Fest, he's cooked up...

Continue Reading
Quay Sunglasses: Luxury Looks, Affordable Prices

Updated Category News Views 3

Ah, sunglasses—the quintessential accessory that screams both practicality and style. A million-dollar look without the million-dollar expense? That's where Quay comes in. They've been recognized by Expert Consumers, no less, as some of the best-in-class for affordable luxury eye candy out there—aimed at shoppers who want the designer vibe without the hemorrhaging...

Continue Reading
Timur Turlov Leads FIDE with Chess and Digital Focus

Updated Category News Views 5

An Unpredicted Victory in Samarkand Well, color me surprised. Timur Turlov's made waves by clinching the role of FIDE President at the General Assembly in Samarkand. This one's quite the turn for the chess world—Kazakhstan’s own stepping up to run the whole show. This isn't just some ceremonial post either. Turlov, who's been pulling strings over at the Kazakhstan...

Continue Reading
PACS Group Faces Legal Scrutiny: What to Watch

Updated Category News Views 5

PACS Group: Legal Storm Brewing Welcome to the latest saga in the volatile theater of corporate governance. PACS Group, Inc., ticker symbol NYSE:PACS, is under the microscope, and not for debuting a groundbreaking product or hitting a stock milestone. Nope, instead we've got Halper Sadeh LLC out of New York investigating some possible hanky-panky from PACS directors and...

Continue Reading
AST SpaceMobile Faces Class Action Over Misstatements

Updated Category News Views 4

What's Going On with AST SpaceMobile? Kicking off with a heavy hitter here, folks. AST SpaceMobile, Inc., trading under NASDAQ:ASTS, is under a securities fraud spotlight. We're talking allegations piled higher than a morning stack of pancakes. If you picked up any ASTS shares between March 4, 2025, and July 15, 2026, you're in on this rough ride. There's a class action...

Continue Reading
Cut Winter Heating Costs with Townsend's Rebate Help

Updated Category News Views 9

Unseen Perils of Winter Heating in Massachusetts Massachusetts homeowners, listen up. If your heating system is older than the Model T, it's time to rethink your winter strategy. You don't want to be stuck in the cold when the thermometer hits single digits, do you? That's where Townsend comes in, making waves with their rebate assistance program. Navigating the Rebate...

Continue Reading
HONA Faces Legal Heat: Investor Lawsuit Over Losses

Updated Category News Views 8

The Investor Storm Brewing Over Honeywell Aerospace There it is again, another industry heavyweight caught in a dizzying whirlwind of litigation. Honeywell Aerospace Inc. (NASDAQ:HONA), a name as established as an old boot in the business, now faces a class action lawsuit that's got investors frantically dusting off phone numbers for their attorneys. The Messy Allegations...

Continue Reading

Top 5 Most Recently Viewed Articles

Find Comfort and Assurance This Fall at Gate of Heaven

Updated Category News Views 97

Experience Comfort and Connection This Fall at Gate of Heaven This autumn, as the leaves turn and a spirit of reflection emerges, families are warmly invited to the Gate of Heaven Cemetery and Mausoleum for a special Fall Open House weekend. This event aims to foster connections among families while providing valuable insights into the significance of memorial planning....

Continue Reading
Lauren Cody to Lead Orangetheory Fitness as Brand President

Updated Category News Views 491

Lauren Cody Takes the Helm at Orangetheory Fitness Purpose Brands, LLC has exciting news! The organization, known for its significant contributions to the fitness, health, and wellness sector, is proudly announcing the appointment of Lauren Cody as the brand president of Orangetheory Fitness. With over twenty-five years of rich experience in leading substantial franchise...

Continue Reading
BofA Downgrades Nissan: Competition Fears and Sales Outlook

Updated Category News Views 126

BofA Downgrades Nissan Shares Due to Rising Competition BofA Securities has decided to downgrade Nissan Motor Co Ltd (OTC: NSANY), changing its stock rating from Buy to Underperform. This notable shift points to worries over various obstacles that might hinder the automaker's performance in the future. Revised Price Target Indicates Ongoing Challenges The investment firm...

Continue Reading
Momcozy Celebrates Community Spirit with Charity Contest Success

Updated Category News Views 206

Momcozy Celebrates the Winners of the Charity Contest Momcozy, a leading global mother and baby brand, is excited to share the results of its 'Love in Action' Charity Contest. This initiative was part of a larger campaign aimed at promoting comfort, health, and well-being for mothers everywhere. In total, $30,000 was awarded to three remarkable organizations that are...

Continue Reading
FDA Approves SELARSDI™: A New Era in Biologics

Updated Category News Views 647

Exciting News: SELARSDI™ Receives FDA Approval Teva Pharmaceuticals, in collaboration with Alvotech, has made significant strides in the field of biosimilars. Recently, the U.S. Food and Drug Administration (FDA) granted approval for SELARSDI™ (ustekinumab-aekn), marking it as interchangeable with the established biologic, Stelara® (ustekinumab). This...

Continue Reading